v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2024 $ (28,973) $ 8 $ 588,576 $ (618,008) $ 451
Beginning balance, Shares at Dec. 31, 2024   3,864,436      
Issuance of common stock upon net exercise of pre-funded warrants, shares   146,468      
Issuance of common stock from RSU vesting and settlement   590      
Issuance of common stock upon PIPE 105,004 $ 1 105,003    
Issuance of common stock upon PIPE, shares   2,103,307      
Costs related to 2025 PIPE offering (3,629)   (3,629)    
Stock-based compensation expense related to employee stock awards 909   909    
Stock-based compensation expense related to employee stock purchases 50   50    
Other comprehensive loss (4)       (4)
Net income (loss) 43,088     43,088  
Ending balance at Mar. 31, 2025 116,445 $ 9 690,909 (574,920) 447
Ending balance, Shares at Mar. 31, 2025   6,114,801      
Beginning balance at Dec. 31, 2024 (28,973) $ 8 588,576 (618,008) 451
Beginning balance, Shares at Dec. 31, 2024   3,864,436      
Other comprehensive loss (31)        
Net income (loss) 27,225        
Ending balance at Jun. 30, 2025 101,866 $ 9 692,220 (590,783) 420
Ending balance, Shares at Jun. 30, 2025   6,151,274      
Beginning balance at Mar. 31, 2025 116,445 $ 9 690,909 (574,920) 447
Beginning balance, Shares at Mar. 31, 2025   6,114,801      
Issuance of common stock related to ESPP purchase 180   180    
Issuance of common stock related to ESPP purchase, shares   36,473      
Costs related to the PIPE offering (29)   (29)    
Stock-based compensation expense related to employee stock awards 1,050   1,050    
Stock-based compensation expense related to employee stock purchases 110   110    
Other comprehensive loss (27)       (27)
Net income (loss) (15,863)     (15,863)  
Ending balance at Jun. 30, 2025 101,866 $ 9 692,220 (590,783) 420
Ending balance, Shares at Jun. 30, 2025   6,151,274      
Beginning balance at Dec. 31, 2025 53,545 $ 9 695,269 (642,201) 468
Beginning balance, Shares at Dec. 31, 2025   6,178,230      
Issuance of common stock related to RSU vesting, shares   9,956      
Stock-based compensation expense related to employee stock awards 1,225   1,225    
Stock-based compensation expense related to employee stock purchases 89   89    
Other comprehensive loss (30)       (30)
Net income (loss) (23,040)     (23,040)  
Ending balance at Mar. 31, 2026 31,789 $ 9 696,583 (665,241) 438
Ending balance, Shares at Mar. 31, 2026   6,188,186      
Beginning balance at Dec. 31, 2025 53,545 $ 9 695,269 (642,201) 468
Beginning balance, Shares at Dec. 31, 2025   6,178,230      
Other comprehensive loss (31)        
Net income (loss) (24,544)        
Ending balance at Jun. 30, 2026 31,884 $ 9 698,183 (666,745) 437
Ending balance, Shares at Jun. 30, 2026   6,236,828      
Beginning balance at Mar. 31, 2026 31,789 $ 9 696,583 (665,241) 438
Beginning balance, Shares at Mar. 31, 2026   6,188,186      
Issuance of common stock related to ESPP purchase 236   236    
Issuance of common stock related to ESPP purchase, shares   48,605      
Issuance of common stock related to RSU vesting, shares   37      
Stock-based compensation expense related to employee stock awards 1,229   1,229    
Stock-based compensation expense related to employee stock purchases 135   135    
Other comprehensive loss (1)       (1)
Net income (loss) (1,504)     (1,504)  
Ending balance at Jun. 30, 2026 $ 31,884 $ 9 $ 698,183 $ (666,745) $ 437
Ending balance, Shares at Jun. 30, 2026   6,236,828